Article Text
Abstract
The right not to know is underappreciated in policy-making. Despite its articulation in medical law and ethics, policy-makers too easily let other concerns override the right not to know. This observation is triggered by a recent decision of the Dutch government on embryo selection for Huntington’s disease. This is a monogenetic debilitating disease without cure, leading to death in early middle age, and thus is a likely candidate for preimplantation genetic diagnosis (PGD). People possibly affected with the Huntington gene do not always want to know their genetic status themselves, which is very burdensome knowledge. For prospective parents, this creates a difficulty in having unaffected children through embryo selection without knowing their own genetic status. A solution is provided by the exclusion test: it allows embryo selection while honouring the parents’ right not to know. The Dutch government however disallowed the exclusion test and chose to allow PGD on Huntington only for parents who test themselves first. To avoid “unnecessary” in-vitro fertilisation procedures for unaffected parents, prospective parents are “forced to know” before they can conceive through embryo selection. This article analyses the scope of the right not to know in the context of embryo selection against Huntington’s disease. It concludes that the right not to know implies that PGD against Huntington should be allowed by means of the exclusion test.
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Britain’s new preimplantation tissue typing policy: an ethical defence
- Extending preimplantation genetic diagnosis: medical and non-medical uses
- Genetic testing and reproductive choice in neurological disorders
- Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?
- Clinical applications of preimplantation genetic testing
- Preimplantation genetic testing
- A brief and personal history of ‘what’s in a name’ in reproductive genetics
- Preimplantation genetic diagnosis in clinical practice
- Three models for the regulation of polygenic scores in reproduction
- An analysis of US fertility centre educational materials suggests that informed consent for preimplantation genetic diagnosis may be inadequate